Simcere Pharmaceutical Group Ltd (2096)

Hong Kong
Currency in HKD
6.81
-0.10(-1.45%)
Closed
2096 Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
6.786.94
52 wk Range
4.987.70
Key Statistics
Edit
Bid/Ask
6.81 / 6.83
Prev. Close
6.81
Open
6.9
Day's Range
6.78-6.94
52 wk Range
4.98-7.7
Volume
2.58M
Average Volume (3m)
4.94M
1-Year Change
32.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2096 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
9.03
Upside
+32.53%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Show more

Simcere Company Profile

Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. The company focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, a simnotrelvir tablets/ritonavir tablets. The company also offers promotion services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients; and property management business. The company has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize SIM0801 and other drugs in the Greater China region; and license and collaboration agreement with Guangzhou Fermion Technology Co., Ltd. to develop FZ002-037, an oral SSTR4 agonist for pain treatment. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China.

Employees
6412
Market
Hong Kong

Compare 2096 to Peers and Sector

Metrics to compare
2096
Peers
Sector
Relationship
P/E Ratio
−14.4x29.3x−0.6x
PEG Ratio
0.11−0.410.00
Price/Book
2.3x2.4x2.6x
Price / LTM Sales
2.5x3.8x3.1x
Upside (Analyst Target)
27.9%42.9%48.7%
Fair Value Upside
Unlock7.7%7.7%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.03
(+32.53% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.428
Dividend Yield
2.58%
Industry Median 2.74%
Annualised payout
0.1757
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / 8.089B
EPS Revisions
Last 90 days

FAQ

What Is the Simcere (2096) Stock Price Today?

The Simcere stock price today is 6.81.

What Stock Exchange Does Simcere Trade On?

Simcere is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Simcere?

The stock symbol for Simcere is "2096."

Does Simcere Pay Dividends? What’s The Current Dividend Yield?

The Simcere dividend yield is 2.58%.

What Is the Simcere Market Cap?

As of today, Simcere market cap is 16.88B.

What is Simcere Earnings Per Share?

The Simcere EPS is -0.428.

From a Technical Analysis Perspective, Is 2096 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.